/R E P E A T -- Canadian Partnership Against Cancer - Media Advisory/



    MONTREAL, June 10 /CNW Telbec/ - Wednesday marks the official launch of
The Canadian Partnership for Tomorrow Project - a study of 300,000 Canadians
that explores how genetics, environment, lifestyle and behaviour contribute to
the development of cancer. The largest of its kind in this country, the
pan-Canadian study will track randomly selected Canadians (ages 35 to 69) for
at least the next 20 to 30 years. It will gather information on health and
lifestyle through surveys and the collection of blood and other specimens. The
information will help researchers, policy-makers and others understand how
different combinations of risk-factors lead to cancer.
    The study is being driven forward by five partner organizations: the BC
Cancer Agency, the Alberta Cancer Board, Quebec's CARTaGENE, Cancer Care
Ontario with the Ontario Institute for Cancer Research and Cancer Care Nova
Scotia with Dalhousie University.

    
    WHAT:     The Canadian Partnership for Tomorrow Press Conference

    WHEN:     Wednesday, June 11, 2008, 10:00 a.m. EST

    WHERE:    Centre Mont Royal
              2200 Mansfield, Room: Cartier 1
              Montreal, QC

    WHO:      Speakers include:

              - Dr. Louis Dionne,
              - Jeff Lozon, Chair, Canadian Partnership Against Cancer
              - Mary O'Neill, Alberta Tomorrow Project Participant
    




For further information:

For further information: or to arrange interviews, please contact: Julie
Holroyde, Hill and Knowlton, (416) 413-4625,
julie.holroyde@hillandknowlton.ca; Geneviève Déry, HKDP Communications and
public affairs, (514) 395-0375, ext. 232, Cell.: (514) 219-2764,
gdery@hkdp.qc.ca


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890